Burden of respiratory syncytial virus infection in older and high-risk adults: a systematic review and meta-analysis of the evidence from developed countries.

"Conflicts of interest: J.S. Nguyen-Van-Tam received no research funding, honoraria, or non-financial benefits, including travel for his role in this or related work. He was seconded less than full-time to the Department of Health and Social Care, England (DHSC) from October 2017 to March 2022, but performed this in his academic capacity at the University of Nottingham. The view expressed in this article are those of the authors and not necessarily those of DHSC. M. O'Leary and T.M.P Tran are employees of P95, a company that received consulting fees from Janssen, Pharmaceutical Companies of Johnson & Johnson. E.T. Martin received no research funding, honoraria, or non-financial benefits, including travel for his role in this or related work. E. Heijnen, B. Callendret and C. Comeaux are employees of Janssen Vaccines and Prevention BV. R. Fleischhackl is an employee of Janssen Research and Development. K. Weber is an employee of Janssen Global Medical Affairs, IDV."

"Support statement: Support was provided by Janssen Pharmaceuticals. Funding information for this article has been deposited with the Crossref Funder Registry."

"We prospectively registered the protocol in PROSPERO (registration number CRD42019156730)."